DIFFERENTIATION OF OVARIAN-CANCER AS A SURVIVAL DETERMINANT FOR ADRIAMYCIN AND CISPLATIN (AP)+/-CYCLOPHOSPHAMIDE AND HEXAMETHYLMELAMINE (CHAP)

被引：0

作者：

BRUCKNER, HW ^{[1
]}

COHEN, CJ ^{[1
]}

GOLDBERG, J ^{[1
]}

DEPPE, G ^{[1
]}

WALLACH, R ^{[1
]}

KABAKOW, B ^{[1
]}

GUSBERG, S ^{[1
]}

HOLLAND, JF ^{[1
]}

机构：

[1] MT SINAI SCH MED,NEW YORK,NY 10029

来源：

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：428 / 428

页数：1

共 50 条

[1] HEXAMETHYLMELAMINE IN OVARIAN-CANCER RESISTANT TO CYCLOPHOSPHAMIDE AND ADRIAMYCIN
BOLIS, G
DINCALCI, M
BELLONI, C
MANGIONI, C
CANCER TREATMENT REPORTS, 1979, 63 (08): : 1375 - 1377
[2] TREATMENT OF CHEMOTHERAPY-RESISTANT ADVANCED OVARIAN-CANCER WITH A COMBINATION OF CYCLOPHOSPHAMIDE, HEXAMETHYLMELAMINE, ADRIAMYCIN, AND CIS-DIAMMINEDICHLOROPLATINUM (CHAP)
BRUCKNER, HW
COHEN, CJ
DEPPE, G
KABAKOW, B
WALLACH, R
RATNER, L
HOLLAND, JF
GYNECOLOGIC ONCOLOGY, 1981, 12 (02) : 150 - 153
[3] CIS DIAMMINEDICHLOROPLATINUM, ADRIAMYCIN, CYCLOPHOSPHAMIDE (PAC) VS HEXAMETHYLMELAMINE, ADRIAMYCIN AND CYCLOPHOSPHAMIDE (HAC) IN ADVANCED OVARIAN-CANCER
MANGIONI, C
BOLIS, G
VALENTE, I
MOLINA, P
SESSA, C
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 166 - 166
[4] RANDOMIZED COMPARISON OF HEXAMETHYLMELAMINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE (HAC) VS CISPLATIN, ADRIAMYCIN, CYCLOPHOSPHAMIDE (PAC) IN ADVANCED OVARIAN-CANCER - LONG-TERM RESULTS
SESSA, C
COLOMBO, N
BOLIS, G
MARSONI, S
MANGIONI, C
CANCER TREATMENT REVIEWS, 1991, 18 : 37 - 46
[5] MODULATION AND INTENSIFICATION OF A CYCLOPHOSPHAMIDE, HEXAMETHYLMELAMINE, DOXORUBICIN, AND CISPLATIN OVARIAN-CANCER REGIMEN
BRUCKNER, HW
COHEN, CJ
FEUER, E
HOLLAND, JF
OBSTETRICS AND GYNECOLOGY, 1989, 73 (03): : 349 - 356
[6] TREATMENT OF OVARIAN-CANCER WITH A COMBINATION OF CIS-PLATINUM, ADRIAMYCIN, CYCLOPHOSPHAMIDE AND HEXAMETHYLMELAMINE
RAZIS, DV
POULAKOU, E
PETOUNIS, A
PAPADIMITRIOU, G
KOSMIDES, P
DELIDES, G
ONCOLOGY, 1982, 39 (04) : 205 - 208
[7] CIS DICHLORODIAMINE PLATINUM (P), ADRIAMYCIN (A), CYCLOPHOSPHAMIDE (C) VERSUS HEXAMETHYLMELAMINE (H), ADRIAMYCIN (A), CYCLOPHOSPHAMIDE (C) IN ADVANCED OVARIAN-CANCER
MANGIONI, C
BOLIS, G
BORTOLOZZI, G
SESSA, C
GARATTINI, S
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 149 - 149
[8] CHAD REGIMEN (CYCLOPHOSPHAMIDE (C), HEXAMETHYLMELAMINE (H), ADRIAMYCIN (A), AND DIAMINEDICHLOROPLATINUM (D) ) IN ADVANCED OVARIAN-CANCER
VOGL, SE
GREENWALD, E
KAPLAN, BH
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 384 - 384
[9] THE ROLE OF HEXAMETHYLMELAMINE IN THE COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CANCER - A COMPARISON OF HEXAMETHYLMELAMINE, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN (H-CAP) VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN (CAP)
HAINSWORTH, JD
JONES, HW
BURNETT, LS
JOHNSON, DH
GRECO, FA
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 410 - 415
[10] HEXAMETHYLMELAMINE, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE (HAC) VERSUS CIS-DICHLORODIAMINEPLATINUM, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE (PAC) IN ADVANCED OVARIAN-CANCER - A RANDOMIZED CLINICAL-TRIAL
SESSA, C
BOLIS, G
COLOMBO, N
DINCALCI, M
MERMILLOD, B
VALENTE, I
MANGIONI, C
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (03) : 222 - 228

← 1 2 3 4 5 →